SHARDACROP
Sharda Cropchem Limited
Global agrochemical marketing and registration company
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
shardacropchem.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Sharda Cropchem (SCL) sells generic crop-protection chemicals (agrochemicals) and holds the product registrations behind them, supplying customers and distributors in 80+ countries while leaving manufacturing to contract manufacturers.
Company snapshot
5thBy market cap
Ranked among 23 companies in Pesticides & Agrochemicals.
Segment mix
Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 82.7% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Agrochemicals | 82.7% | 769 Cr | 7 Cr | 3,266 Cr |
| Non-agrochemicals | 17.3% | 161 Cr | 35 Cr | 167 Cr |
What we see
- ✓Interest coverage of 427.9x — earnings comfortably cover interest obligations.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 581 Cr | 632 Cr | 1,312 Cr | 785 Cr | 777 Cr | 929 Cr | 1,829 Cr | 985 Cr | 929 Cr | 1,289 Cr | 2,065 Cr | 1,074 Cr |
| Operating expenses (approx.) | 560 Cr | 563 Cr | 1,057 Cr | 708 Cr | 687 Cr | 815 Cr | 1,525 Cr | 770 Cr | 796 Cr | 1,048 Cr | 1,578 Cr | 888 Cr |
| EBITDA | 21 Cr | 69 Cr | 255 Cr | 77 Cr | 90 Cr | 115 Cr | 303 Cr | 215 Cr | 133 Cr | 241 Cr | 487 Cr | 186 Cr |
| OPM % | 3.6% | 11.0% | 19.4% | 9.8% | 11.5% | 12.3% | 16.6% | 21.9% | 14.3% | 18.7% | 23.6% | 17.3% |
| Other income | 24 Cr | 12 Cr | -2 Cr | 19 Cr | 25 Cr | 0.62 Cr | 25 Cr | 32 Cr | 29 Cr | 21 Cr | 22 Cr | 35 Cr |
| Interest | 5 Cr | 0.90 Cr | 0.15 Cr | 0.76 Cr | 0.48 Cr | 0.45 Cr | 0.41 Cr | 0.56 Cr | 0.34 Cr | 0.39 Cr | 0.47 Cr | 2 Cr |
| Depreciation | 74 Cr | 69 Cr | 54 Cr | 65 Cr | 69 Cr | 69 Cr | 72 Cr | 78 Cr | 76 Cr | 83 Cr | 87 Cr | 100 Cr |
| Profit before tax | -34 Cr | 12 Cr | 198 Cr | 31 Cr | 46 Cr | 46 Cr | 256 Cr | 169 Cr | 86 Cr | 179 Cr | 422 Cr | 118 Cr |
| Tax % | 18.5% | 61.7% | 27.7% | 11.5% | 6.8% | 32.2% | 20.5% | 15.6% | 13.3% | 18.7% | 24.5% | 25.7% |
| Net profit | -28 Cr | 5 Cr | 143 Cr | 27 Cr | 42 Cr | 31 Cr | 204 Cr | 143 Cr | 74 Cr | 145 Cr | 319 Cr | 88 Cr |
| EPS (₹) | ₹-3.06 | ₹0.51 | ₹15.90 | ₹3.02 | ₹4.70 | ₹3.45 | ₹22.57 | ₹15.83 | ₹8.24 | ₹16.09 | ₹35.32 | ₹9.76 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,399 Cr | 1,713 Cr | 2,001 Cr | 2,003 Cr | 2,396 Cr | 3,580 Cr | 4,045 Cr | 3,163 Cr | 4,320 Cr | 5,268 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 1,087 Cr | 1,368 Cr | 1,676 Cr | 1,721 Cr | 1,959 Cr | 2,897 Cr | 3,402 Cr | 2,880 Cr | 3,724 Cr | 4,191 Cr | Sign in free for the trailing twelve months |
| EBITDA | 312 Cr | 345 Cr | 325 Cr | 282 Cr | 437 Cr | 683 Cr | 643 Cr | 283 Cr | 596 Cr | 1,076 Cr | Sign in free for the trailing twelve months |
| OPM % | 22.3% | 20.2% | 16.2% | 14.1% | 18.2% | 19.1% | 15.9% | 8.9% | 13.8% | 20.4% | Sign in free for the trailing twelve months |
| Other income | 16 Cr | 17 Cr | 18 Cr | 42 Cr | 46 Cr | 29 Cr | 40 Cr | 60 Cr | 60 Cr | 106 Cr | Sign in free for the trailing twelve months |
| Interest | 0.05 Cr | 5 Cr | 8 Cr | 2 Cr | 3 Cr | 2 Cr | 5 Cr | 4 Cr | 2 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Depreciation | 56 Cr | 70 Cr | 99 Cr | 137 Cr | 170 Cr | 245 Cr | 248 Cr | 267 Cr | 275 Cr | 325 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 272 Cr | 287 Cr | 235 Cr | 185 Cr | 309 Cr | 464 Cr | 431 Cr | 72 Cr | 378 Cr | 856 Cr | Sign in free for the trailing twelve months |
| Tax % | 29.9% | 33.6% | 25.0% | 10.9% | 25.9% | 24.8% | 20.6% | 55.6% | 19.5% | 20.4% | Sign in free for the trailing twelve months |
| Net profit | 190 Cr | 191 Cr | 176 Cr | 165 Cr | 229 Cr | 349 Cr | 342 Cr | 32 Cr | 304 Cr | 681 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹21.11 | ₹21.15 | ₹19.55 | ₹18.25 | ₹25.40 | ₹38.71 | ₹37.90 | ₹3.53 | ₹33.74 | ₹75.47 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 7.9% | 15.5% | 16.2% | 84.6% | 18.2% | 16.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 90 Cr | 90 Cr | 90 Cr | 90 Cr | 90 Cr | 90 Cr | 90 Cr | 90 Cr | 90 Cr | 90 Cr |
| Reserves | 870 Cr | 1,045 Cr | 1,194 Cr | 1,313 Cr | 1,524 Cr | 1,822 Cr | 2,142 Cr | 2,147 Cr | 2,410 Cr | 3,046 Cr |
| Borrowings | 0.24 Cr | 170 Cr | 0.09 Cr | 0.09 Cr | 68 Cr | 38 Cr | 3 Cr | 3 Cr | — | — |
| Other liabilities | 690 Cr | 921 Cr | 919 Cr | 944 Cr | 1,181 Cr | 1,792 Cr | 2,115 Cr | 1,797 Cr | 2,224 Cr | 2,643 Cr |
| Total liabilities | 1,650 Cr | 2,226 Cr | 2,203 Cr | 2,347 Cr | 2,864 Cr | 3,743 Cr | 4,351 Cr | 4,038 Cr | 4,725 Cr | 5,780 Cr |
| Fixed assets (net) | 0.96 Cr | 11 Cr | 14 Cr | 28 Cr | 21 Cr | 14 Cr | 5 Cr | 18 Cr | 10 Cr | 3 Cr |
| CWIP | 1 Cr | — | 220 Cr | 161 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Investments | 61 Cr | 22 Cr | 212 Cr | 116 Cr | 83 Cr | 134 Cr | 32 Cr | 159 Cr | 294 Cr | 361 Cr |
| Loans & advances | — | — | 0.0009 Cr | 0.0003 Cr | 0 Cr | 0.50 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 288 Cr | 530 Cr | 365 Cr | 382 Cr | 526 Cr | 893 Cr | 1,134 Cr | 992 Cr | 972 Cr | 1,120 Cr |
| Trade receivables | 673 Cr | 892 Cr | 811 Cr | 989 Cr | 1,163 Cr | 1,540 Cr | 1,833 Cr | 1,498 Cr | 1,955 Cr | 2,389 Cr |
| Cash & bank | 72 Cr | 61 Cr | 51 Cr | 78 Cr | 86 Cr | 57 Cr | 176 Cr | 87 Cr | 127 Cr | 220 Cr |
| Other assets | 554 Cr | 710 Cr | 531 Cr | 593 Cr | 986 Cr | 1,104 Cr | 1,170 Cr | 1,284 Cr | 1,366 Cr | 1,688 Cr |
| Total assets | 1,650 Cr | 2,226 Cr | 2,203 Cr | 2,347 Cr | 2,864 Cr | 3,743 Cr | 4,351 Cr | 4,038 Cr | 4,725 Cr | 5,780 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 181 Cr | 17 Cr | — | — | 249 Cr | 267 Cr | 328 Cr | 341 Cr | 604 Cr | 656 Cr |
| Cash from investing | -104 Cr | -163 Cr | — | — | -284 Cr | -208 Cr | -145 Cr | -393 Cr | -510 Cr | -513 Cr |
| Cash from financing | -38 Cr | 132 Cr | — | — | 43 Cr | -91 Cr | -97 Cr | -37 Cr | -68 Cr | -118 Cr |
| Net cash flow | 40 Cr | -11 Cr | — | — | 8 Cr | -29 Cr | 119 Cr | -88 Cr | 40 Cr | 93 Cr |
| Free cash flow (OCF − Capex) | 39 Cr | -185 Cr | — | — | 15 Cr | 33 Cr | 84 Cr | 69 Cr | 211 Cr | 158 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 28.3% | 22.4% | 19.0% | 13.3% | 18.6% | 23.9% | 19.5% | 3.4% | 15.2% | 27.3% |
| ROE % | 19.8% | 16.8% | 13.7% | 11.7% | 14.2% | 18.3% | 15.3% | 1.4% | 12.2% | 21.7% |
| Debtor days | 175 | 189 | 148 | 180 | 177 | 157 | 165 | 173 | 165 | 165 |
| Inventory days | 245 | 305 | 188 | 180 | 204 | 244 | 266 | 244 | 199 | 183 |
| Days payable | 389 | 374 | 327 | 323 | 313 | 322 | 323 | 227 | 268 | 245 |
| Cash conversion cycle | 31 | 121 | 8 | 37 | 68 | 79 | 108 | 190 | 95 | 103 |
| OCF / EBITDA % | 58.1% | 4.9% | — | — | 56.9% | 39.1% | 51.0% | 120.7% | 101.4% | 60.9% |
| OCF / EBITDA % (3 years) | — | — | — | — | — | — | 47.9% | 58.2% | 83.7% | 81.9% |
| Debt / equity | 0.0003 | 0.15 | 0.0001 | 0.0001 | 0.04 | 0.02 | 0.0013 | 0.0015 | — | — |
| Current ratio | 1.90 | 1.56 | 1.88 | 1.96 | 1.84 | 1.69 | 1.65 | 1.86 | 1.81 | 1.86 |
| Net debt / EBITDA | -0.23 | — | -0.16 | -0.28 | -0.04 | -0.03 | -0.27 | -0.30 | -0.21 | -0.20 |